GRSF1: A Potential Drug Target for Cancer and Cardiovascular Diseases

Target Name: GRSF1

NCBI ID: G2926

GRSF1

GRSF1: A Potential Drug Target for Cancer and Cardiovascular Diseases

GRSF1 (FLJ13125) is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a crucial role in cellular signaling. GRSF1 is highly conserved and has a well-established function in several physiological processes, including cell survival, growth, and angiogenesis.

GRSF1 is involved in several signaling pathways that are critical for human health and disease. One of the most well-studied functions of GRSF1 is its role in the regulation of cell survival and proliferation. GRSF1 has been shown to play a critical role in the regulation of cell survival by promoting the survival of neurons and other cell types.

GRSF1 has also been shown to play a key role in the regulation of cell growth and angiogenesis. GRSF1 has been shown to promote the growth and survival of vascular smooth muscle cells, which are important for maintaining blood vessel integrity and blood flow. In addition, GRSF1 has been shown to promote the growth and survival of cancer cells, which is a critical step in the development and progression of many diseases.

GRSF1 is also involved in the regulation of inflammation and immune responses. GRSF1 has been shown to play a critical role in the regulation of inflammation and immune responses by promoting the recruitment of immune cells to the site of an infection or injury.

GRSF1 is a potential drug target for several diseases. For example, GRSF1 has been shown to be highly expressed in cancer cells and has been shown to play a critical role in the regulation of cancer cell growth and survival. Therefore, GRSF1 may be an attractive target for cancer therapies. In addition, GRSF1 has also been shown to play a key role in the regulation of cardiovascular disease, so it may also be a potential target for cardiovascular therapies.

In conclusion, GRSF1 is a protein that is involved in several critical signaling pathways that are important for human health and disease. Its functions include cell survival, growth, angiogenesis, inflammation, and immune responses. As a result, GRSF1 may be a valuable drug target for the treatment of several diseases. Further research is needed to fully understand the functions of GRSF1 and to develop effective therapies that target this protein.

Protein Name: G-rich RNA Sequence Binding Factor 1

Functions: Regulator of post-transcriptional mitochondrial gene expression, required for assembly of the mitochondrial ribosome and for recruitment of mRNA and lncRNA. Binds RNAs containing the 14 base G-rich element. Preferentially binds RNAs transcribed from three contiguous genes on the light strand of mtDNA, the ND6 mRNA, and the long non-coding RNAs for MT-CYB and MT-ND5, each of which contains multiple consensus binding sequences (PubMed:23473033, PubMed:23473034, PubMed:29967381). Involved in the degradosome-mediated decay of non-coding mitochondrial transcripts (MT-ncRNA) and tRNA-like molecules (PubMed:29967381). Acts by unwinding G-quadruplex RNA structures in MT-ncRNA, thus facilitating their degradation by the degradosome (PubMed:29967381). G-quadruplexes (G4) are non-canonical 4 stranded structures formed by transcripts from the light strand of mtDNA (PubMed:29967381)

The "GRSF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GRSF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets